Pfeiffer Vacuum apprentices win award for virtual training film
Avoids translation misunderstandings as pumps firm expands into Asia
Alena Bölzer, Meike König, Oxana Pozdeev and Lisa Weichl won the ‘Unique products and services’ category for their virtual training films, which explain the steps involved in handling individual turbo pumps and other Pfeiffer Vacuum products. The films are practically speech-free so that any misunderstandings in language translation are avoided.
‘We are proud of our young employees,’ said Matthias Wierner, executive board member responsible for marketing, production and development at Pfeiffer Vacuum Technology. ‘They have not only had a great idea and implemented it well but have also presented their results professionally. Pfeiffer Vacuum will this year become even more international with a clear orientation towards Asia. We are very pleased that this situation is being addressed constructively and innovatively by all our staff.’
The company recently set up a subsidiary in São Paulo, Brazil and now has its own subsidiaries in Brazil, Russia, India and China.
Pfeiffer Vacuum reported unaudited sales of €220.5m in 2010, an increase of 21%.
You may also like
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing
Piramal Pharma Solutions announces partnership with Botanix to support drug substance development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing
ProtaGene and Merck partner to deliver end-to-end biologics testing
The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle